See other companies on Welcome to the Jungle
Ozette Technologies
AI-driven immune system digitization platform
- 21-100 employees
- B2B
- Artificial Intelligence
- Biology
- Science
- MedTech
- Northlake, Seattle, WA
Jump to section
Company mission
To unlock the immune system to prevent disease through novel computational biology methods.
Our take
Deep understandings of systems found in nature allow us to represent biological systems through data and thus lead to research. This includes the study of the human immune system, but the system is incredibly complex and thus holds far too much data for human minds to analyze and learn from efficiently.
Ozette develops an AI-driven immune system digitization platform, helping to map and study the system to unlock insights, accelerate research, and develop medicines and therapies for all. The computational technology will eventually branch out to many areas of study within the immune system but is currently focused on immuno-oncology drug development for the treatment of cancer.
Whilst AI is already being used to augment the analysis of synthetic proteins, medical health records, and other healthcare datasets, Ozette has taken a unique approach to applying the technology directly to the study of the human immune system. Through this approach, the platform shows great potential to increase the speed at which we can study the essential biological system and therefore fuel exponential research into life-changing drugs.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- A hybrid office schedule with many employees opting for full-time remote
- All 11 federal holidays + an additional extra day off for every holiday
- A weeklong respite the week of Thanksgiving and a two-week respite the last two weeks of the year
- A ‘take what you need’ vacation policy
- Full benefits (medical, dental, visions, 401K, FSA)
- Team Lunch Tuesdays (paid lunch in office and remote)
Funding (2 rounds)
Jul 2022
$26m
SERIES A
Feb 2021
$6m
SEED
Total funding: $32m
This company has top investors
Leadership
Ali Ansary
(Co-Founder & CEO)Experience as Co-founder and Board Member of SeventyK. Attending Physician at University of Washington Medical Center's Fred Hutch Cancer Center since 2020.
Greg Finak
(Co-Founder & CTO)Experience as Co-founder and Scientific Advisor for Cellspace Biosciences Inc. Post Doctoral Research Associate and Senior Staff Scientist at Fred Hutch from 2010 to 2021.
Raphael Gottardo
(Co-Founder)Experience as Scientific Director of Fred Hutch. Director of the Biomedical Data Sciences Center at Lausanne University Hospital's CHUV since 2021.
Evan Greene
(Co-Founder)Postdoctoral Research Fellow and Data Scientist for Fred Hutch from 2016 to 2021.
Diversity, Equity & Inclusion at Ozette Technologies
- Our work and teams thrive most when we are diverse and inclusive, so we take equal opportunity seriously. We commit to fostering a respectful, diverse, and inclusive environment where all team members can contribute and develop to their fullest potential. We welcome individuals of all backgrounds, orientations, and identities to join our community. Applications from women and members of underrepresented minority groups are particularly welcomed.